FORA Capital LLC Cuts Holdings in Haleon plc (NYSE:HLN)

FORA Capital LLC lowered its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 87.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,405 shares of the company's stock after selling 84,587 shares during the quarter. FORA Capital LLC's holdings in Haleon were worth $118,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Procyon Advisors LLC boosted its position in Haleon by 41.3% during the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company's stock valued at $2,196,000 after purchasing an additional 67,329 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Haleon by 29.8% during the fourth quarter. Bank of New York Mellon Corp now owns 2,071,017 shares of the company's stock valued at $19,758,000 after purchasing an additional 475,934 shares in the last quarter. SeaCrest Wealth Management LLC bought a new stake in Haleon during the fourth quarter valued at about $102,000. Atria Wealth Solutions Inc. boosted its position in Haleon by 6.1% during the fourth quarter. Atria Wealth Solutions Inc. now owns 47,868 shares of the company's stock valued at $457,000 after purchasing an additional 2,758 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its position in Haleon by 13.3% during the fourth quarter. Janney Montgomery Scott LLC now owns 850,563 shares of the company's stock valued at $8,114,000 after purchasing an additional 99,666 shares in the last quarter. Institutional investors own 6.67% of the company's stock.

Haleon Price Performance

Shares of Haleon stock traded down $0.03 on Wednesday, reaching $10.42. The company's stock had a trading volume of 26,034,279 shares, compared to its average volume of 7,933,370. The company has a market capitalization of $47.00 billion, a P/E ratio of 30.65, a PEG ratio of 2.82 and a beta of 0.24. Haleon plc has a 52-week low of $8.25 and a 52-week high of $10.85. The stock has a 50-day moving average price of $10.21 and a 200-day moving average price of $9.85. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. Analysts expect that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The firm also recently announced a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be given a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. This is an increase from Haleon's previous -- dividend of $0.05. Haleon's payout ratio is currently 58.97%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on HLN shares. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Barclays restated an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. HSBC reiterated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Morgan Stanley upgraded Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target for the company in a research report on Friday, May 9th. Finally, Hsbc Global Res cut Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Five investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Haleon presently has an average rating of "Moderate Buy" and an average price target of $11.25.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.